ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,704Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 2680

$1.2M Total Retail Price of All Prescriptions

Rank: 33 out of 2680

404 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 11,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 485 410 1 3
OMEPRAZOLE 456 380 2 2
NEXIUM 398 283 3 19
CRESTOR 386 315 4 15
SIMVASTATIN 344 307 5 1
METOPROLOL TARTRATE 333 312 6 8
LOVAZA 323 220 7 47
ZOLPIDEM TARTRATE 244 152 8 17
FUROSEMIDE 226 161 9 7
ENALAPRIL MALEATE 221 188 10 24
LOSARTAN-HYDROCHLOROTHIAZIDE 219 175 11 46
IBUPROFEN 206 140 12 63
METFORMIN HCL 182 147 13 6
DIOVAN HCT 161 131 14 54
TAMSULOSIN HCL 158 152 15 25
PROAIR HFA 158 110 15 52
ALENDRONATE SODIUM 157 139 17 20
HYDROCHLOROTHIAZIDE 157 148 17 9
LIDOCAINE-PRILOCAINE 147 104 19 318
METOPROLOL SUCCINATE 146 123 20 11
CREON 140 126 21 112
CARVEDILOL 136 119 22 27
LIDODERM 132 120 23 74
RANITIDINE HCL 131 87 24 35
MECLIZINE HCL 128 118 25 105
TRAMADOL HCL 128 64 25 33
JANUVIA 123 111 27 34
PLAVIX 118 106 28 41
SYNTHROID 116 85 29 39
LYRICA 116 85 29 107
BENICAR HCT 115 77 31 125
JANUMET 115 83 31 83
FLUTICASONE PROPIONATE 114 61 33 38
ATORVASTATIN CALCIUM 114 91 33 10
AMLODIPINE BESYLATE-BENAZEPRIL 109 91 35 58
VOLTAREN 107 80 36 103
FAMOTIDINE 106 77 37 65
SINGULAIR 105 56 38 64
AZITHROMYCIN 104 80 39 40
DEXILANT 104 96 39 133
POTASSIUM CHLORIDE 103 74 41 29
MELOXICAM 102 90 42 50
CLOPIDOGREL 97 88 43 30
GLIPIZIDE XL 97 85 43 87
ZOVIRAX 95 90 45 301
VENTOLIN HFA 90 37 46 61
AVODART 90 90 46 165
NIFEDIPINE ER 89 86 48 73
NAMENDA 89 89 48 43
ZETIA 88 88 50 69
ATENOLOL 87 71 51 14
ADVAIR DISKUS 86 64 52 32
LIPITOR 85 75 53 78
RAMIPRIL 85 85 53 49
ACTOS 83 71 55 98
CICLOPIROX 81 60 56 248
WARFARIN SODIUM 79 68 57 12
AMMONIUM LACTATE 79 59 57 118
DIOVAN 78 74 59 26
DONEPEZIL HCL 77 67 60 28
CIPROFLOXACIN HCL 76 61 61 85
CHLORHEXIDINE GLUCONATE 75 41 62 166
BYSTOLIC 74 48 63 104
LANSOPRAZOLE 73 52 64 121
CELEBREX 73 68 64 75
LISINOPRIL 73 56 64 5
PATANOL 73 70 64 239
GABAPENTIN 70 67 68 21
SOLARAZE 69 62 69 172
GLYBURIDE-METFORMIN HCL 67 63 R 70 96
NASONEX 66 51 71 206
CYCLOBENZAPRINE HCL 65 17 R 72 95
TRAZODONE HCL 65 41 72 60
DICYCLOMINE HCL 64 42 74 267
CLONIDINE HCL 63 46 75 84
MOMETASONE FUROATE 61 34 76 245
MICARDIS HCT 60 45 77 205
CYMBALTA 58 44 78 56
SINGLE USE SWAB 57 52 79 196
LEVOTHYROXINE SODIUM 57 34 79 4
FLECTOR 55 38 81 316
GLIMEPIRIDE 55 54 81 51
ISOSORBIDE MONONITRATE ER 55 44 81 57
SERTRALINE HCL 54 24 84 23
SPIRIVA 54 27 84 36
BENICAR 51 50 86 122
COUMADIN 50 50 87 154
CIPRODEX 50 37 87 565
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.